Physician

Christopher A Haddad, M.D.

According to 2025 Medicare claims, Christopher Haddad, M.D. (NPI: 1912987264) practices cardiology in the San Angelo, TX market, with the plurality of this provider's patient population coming from Tom Green, TX. This provider's primary affiliated billing organization is SHANNON CLINIC (NPI: 1770587149; TIN: 752600873) and primary practice location at 76903-5904. Haddad is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Haddad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,390 traditional Medicare patients, billed 7,413 HCPCS/CPT codes, and received $433,014 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 13,065 prescription claims across 1,821 beneficiaries totaling $1,716,750 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 11 claims. Open Payments data shows 76 records totaling $1,866. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $261,767 to $1,716,750. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $53,481 and ending at $25,535.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,779	5,887	$413,128
2016	1,992	7,985	$556,595
2017	2,177	9,002	$643,200
2018	2,172	11,858	$799,358
2019	2,239	13,621	$853,837
2020	2,205	12,564	$799,503
2021	2,358	8,206	$512,900
2022	2,309	7,048	$414,034
2023	2,272	7,255	$408,550
2024	2,390	7,413	$433,014

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	544	4,508	$261,767
2016	786	6,981	$456,368
2017	1,029	8,689	$683,654
2018	1,146	10,138	$877,566
2019	1,298	11,099	$1,029,689
2020	1,452	12,538	$1,301,521
2021	1,534	12,496	$1,392,909
2022	1,600	12,459	$1,522,073
2023	1,695	13,203	$1,834,120
2024	1,821	13,065	$1,716,750

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	64	$103,856
2016	N/R	94	$66,411
2017	N/R	72	$57,578
2018	13	109	$76,753
2019	N/R	77	$38,927
2020	11	36	$76,698
2021	N/R	23	$52,180
2022	N/R	11	$25,535
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,175	1,240	$86
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	1,389	1,500	$52
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	804	1,007	$11
93018	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician	232	237	$11
36415	Insertion of needle into vein for collection of blood sample	1,035	1,205	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	515	29,572	$546,131
Entresto	Sacubitril/Valsartan	220	10,806	$221,810
Repatha Sureclick	Evolocumab	228	11,745	$219,526
Brilinta	Ticagrelor	216	11,670	$166,487
Xarelto	Rivaroxaban	171	9,125	$160,906

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	76	$1,866	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher A. Haddad, M.D.?

Tedicare shows public-source Medicare data for Christopher A. Haddad, M.D. (NPI 1912987264), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher A. Haddad, M.D. have ACO affiliation data?

Christopher A. Haddad, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Christopher A. Haddad, M.D.?

Christopher A. Haddad, M.D. is linked to SHANNON CLINIC (billing NPI 1770587149) in the available physician profile data.

Does Christopher A. Haddad, M.D. have Open Payments data?

Christopher A. Haddad, M.D. has 76 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.